Hebei reimburses 70%! New crown infection and suspected patients can be reimbursed for outpatient and emergency expenses in primary care institutions

Read Time:1 Minute, 50 Second

Recently, the Hebei Provincial Medical Security Bureau, Hebei Provincial Department of Finance, Hebei Provincial Health and Health Commission recently jointly issued a “notice on the transfer of the National Health Insurance Bureau, Ministry of Finance, National Health and Health Commission, National Disease Control Bureau on the implementation of the “Class B B tube” after the optimization of medical insurance policies related to the treatment costs of patients with new coronavirus infection.

The reimbursement ratio for emergency outpatient expenses is unified at 70% in the province

The “Notice” requires the implementation of special protection for emergency outpatient expenses of patients with new coronavirus infection and suspected symptoms occurring in primary medical insurance designated medical institutions (secondary and lower medical institutions), and the emergency outpatient expenses related to the treatment of new coronavirus infection occurring in primary medical insurance designated medical institutions for insured patients, without setting a starting line and a cap line, with a reimbursement ratio of 70% unified across the province, to be implemented first until March 31, 2023.

>
Temporary expansion of the medical insurance drug list

New coronavirus treatment drugs that are not included in the basic medical insurance catalog in the treatment plan for new coronavirus infection will be temporarily included in the scope of payment of medical insurance funds, with reference to the management of Class A drugs, and will be implemented until March 31, 2023. The new coronavirus treatment drugs identified by the Hebei Provincial Leading Group Office or the Medical Treatment Group will be temporarily included in the scope of payment of medical insurance funds after being reported to the National Health Insurance Bureau for the record, and will be implemented until March 31, 2023.

>
Effectively protect the demand for drugs

Do a good job of national new coronavirus infection patient treatment required drugs and other price negotiations or consultation results in Hebei Province to land work. For clinical necessity, the provincial medical drugs centralized procurement platform no enterprise supply of drugs, medical institutions can search for manufacturers offline, and enterprises to agree on prices after the first purchase, in a timely manner in the provincial medical drugs centralized procurement platform to fill the purchase order information.